Listed by the USPTO as ABBAS, SYED JARAR
Tech Center 1600 • Art Units: 1618 1645 1656 1674
This examiner grants 25% of resolved cases
ABBAS, SYED JARAR is assigned to Tech Center 1600 and Art Unit 1618. The profile contains 4 resolved cases, with a 25.0% allowance rate and a median of 1257 days to allowance. The interview lift is 0.0%, so the available record does not show an interview-associated change in allowance outcomes.
Novartis AG, Wisconsin Alumni Research Foundation, and THE GENERAL HOSPITAL Corporation are the leading companies represented. The listed firms are CHALKER FLORES, LLP, Chen Yoshimura LLP, and Clark+Elbing LLP. Because the case base is small, practitioners should use these figures as limited historical context rather than as a broad prediction of examination behavior.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18043716 | CHIMERIC RECEPTORS WITH DIVERSE CO-REGULATORY SEQUENCES | Final Rejection | The Regents of the University of California |
| 18277576 | INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy25.0% of resolved applications examined by Syed Jarar Abbas were allowed (4 resolved cases), compared with 33.1% across Art Unit 1618 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Syed Jarar Abbas took 1,257 days on average from filing to allowance.
Syed Jarar Abbas examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
